Astrana Health (ASTH) and Its Rivals Head-To-Head Survey

Astrana Health (NASDAQ:ASTH) is one of 65 public companies in the “Management consulting services” industry, but how does it contrast to its peers? We will compare Astrana Health to related businesses based on the strength of its profitability, risk, earnings, valuation, analyst recommendations, institutional ownership and dividends.

Analyst Ratings

This is a breakdown of current ratings and recommmendations for Astrana Health and its peers, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Astrana Health	0	1	1	0	2.50
Astrana Health Competitors	68	530	1407	58	2.71

Astrana Health currently has a consensus target price of $47.00, suggesting a potential upside of 14.30%. As a group, “Management consulting services” companies have a potential upside of 18.47%. Given Astrana Health’s peers stronger consensus rating and higher probable upside, analysts plainly believe Astrana Health has less favorable growth aspects than its peers.

Profitability

This table compares Astrana Health and its peers’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Astrana Health	4.49%	11.52%	6.67%
Astrana Health Competitors	-68.13%	-348.99%	-12.79%

Volatility and Risk

Astrana Health has a beta of 1.1, meaning that its share price is 10% more volatile than the S&P 500. Comparatively, Astrana Health’s peers have a beta of 0.89, meaning that their average share price is 11% less volatile than the S&P 500.

Valuation & Earnings

This table compares Astrana Health and its peers top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Astrana Health	$1.39 billion	$60.72 million	31.15
Astrana Health Competitors	$1.64 billion	$114.49 million	11.20

Astrana Health’s peers have higher revenue and earnings than Astrana Health. Astrana Health is trading at a higher price-to-earnings ratio than its peers, indicating that it is currently more expensive than other companies in its industry.

Insider & Institutional Ownership

52.8% of Astrana Health shares are owned by institutional investors. Comparatively, 45.2% of shares of all “Management consulting services” companies are owned by institutional investors. 8.5% of Astrana Health shares are owned by insiders. Comparatively, 28.8% of shares of all “Management consulting services” companies are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Summary

Astrana Health peers beat Astrana Health on 7 of the 13 factors compared.

About Astrana Health

Apollo Medical Holdings, Inc. engages in the provision of healthcare services. It offers integrated care, inpatient and physician alignment solutions. The company focuses on physicians providing high-quality medical care, population health management and care coordination for patients, particularly senior patients and patients with multiple chronic conditions. Apollo Medical Holdings, Inc. is headquartered in Glendale, CA.